chrisvoncsefalvay/vaers-outcomes huggingface dataset:
2/11/22 pt brought to the hospital with generalized weakness, poor oral intake, less alert, coughing over the past week; found to be positive for COVID and UTI; admitted to ICU; respiratory status without distress; given ABX; DNR; acute on chronic renal failure, failure to thrive, sepsis; DVT in right upper extremity, started Heparin drip; pt eventually dc'd to home 2/19/22 where she passed away
PARALYSIS ON BOTH SIDES OF HIS BODY; This spontaneous report received from a consumer via social media platform concerned a male of unspecified age.. The patient's weight, height, and medical history were not reported.  The patient received Covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose,1 total dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. Per procedure no follow up will be requested for this case. No concomitant medications were reported.  The patient was paralyzed on both sides of body for a month and had no improvement. The patient had vaccine and on day 5 after vaccination issue had started. On day 9 after vaccination, the patient was paralyzed and still had at the time of this report. The patient's physician stated the patient was perfectly healthy no medical issues, it was the vaccine that caused it. The patient was not better at the time of this report. The action taken with Covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from paralysis on both sides. This report was serious (Other Medically Important Condition).; Sender's Comments: V0.  20210524291- Covid-19 vaccine ad26.cov2.s-Paralysis. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).
PATIENT UNDER THE AGE OF 12 YEARS CURRENT AGE 6 YEAR OLD.   On 9/25/21  patient came  into office  for  second  COVID-19 Pfizer  vaccine,  was  given  1st vaccine on 9/4/2021,  that  should not  have  been given.  Second  dose was not given  &  this  was  explained to the  mother. Dr. discussed  this with  mother  on 9/27/2021.Fatigue started 4 days after vaccine. Going to sleep early during the week. Napping during the weekend. Eczema flared after vaccine. Asthma has been stable.
This is a spontaneous report from a Non contactable consumer (patient). A patient of unspecified age and gender received the first dose of BNT162B2 (COVID-19 VACCINE) at single dose for COVID-19 immunization. Medical history included patient was in the hospital in ICU on the ventilator about 7 months ago with COVID, patient was still recovering from it. Concomitant medications were not reported. Patient just got some questions, patient was in the hospital in ICU on the ventilator about 7 months ago with COVID, patient was still recovering from it. Patient just had the first shot of COVID vaccine yesterday morning. Patient woke up this morning, Patient had fever and chills and arm pain, Patient was not worried about, patient got fatigue. Patient was just wondering if because potentially still have the antibodies there that would cause like do an extra reaction. Confirmed that the consumer got the COVID 19 Vaccine shot. Patient had first shot yesterday morning, like back in August and September patient was in a hospital and on the Ventilator in the ICU, so patient knew had bad, patient didn't think patient was going to live. Patient woke up this morning with 104 fever, chill, and even fatigued. Patient was not concerned, patient even got the arm pain, the injection site, Patient was not worried about that. Patient concern was what was mean, patient's wife got the same shot but she had no trouble. Sister-in-laws, brothers-in-law, friends took the same the shot, they did not have any trouble. Patient was wondering if because patient had COVID so severe that there would still be antibodies that would make body, if patient get the shot that can do something to your body that can start developing the antibodies to fight. If patient already had the antibodies in there and the vaccination still going in body and patient getting sick again. Asked if there would be more immediate and drastic response to the vaccinations. Events seriousness was unspecified. Outcome of events was unknown. No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Infant noted to have fever, became less responsive, had a period of apnea 10-15 seconds, felt to be very limp and unresponsive. Call 911 and taken to the hospital for observation.
Day after pneumonia shot, sore arm, 2 days later left arm swollen, red and hot to the touch starting about 1" from where pneumonia shot was given. Red streaks going down arm towards hand. Went to urgent care. Was told by doctor it was either a reaction to the needle or to the medicine. Diagnosed with cellulitis and put on Cephalexin and Allegra, when I spoke with pt on 10/24 swelling gone and almost back to normal.
No adverse events reported. Patient was 10 years old and received vaccine approved for 12 years and older due to parent falsifying date of birth.
Discharge Provider: PRIVATE, MD Primary Care Provider: PRIVATE, DO Admission Date: 12/11/2022 Discharge Date: Dec 16, 2022 COVID positive Date: 12/11/2022  PRESENTING PROBLEM: Hyponatremia [E87.1] Hypotension, unspecified hypotension type [I95.9] COVID-19 [U07.1]   HOSPITAL COURSE:   Patient is a 51-year-old male with history of type 2 diabetes mellitus, hypothyroidism and hyperlipidemia who presented with generalized weakness and fatigue for 2-3 days.  In the emergency department, he had mild hypotension.  Labs were significant for sodium of 125, AST 66 an ALT of 72. He tested positive for COVID-19.  Chest x-ray was unremarkable.  He was given 2 L of normal saline and admitted to the hospitalist service for further care.   Upon admit was continued on IV normal saline. He did develop hyperkalemia, hypomagnesemia and hypocalcemia.  His hyperkalemia improved without intervention, but he was supplemented with IV calcium and magnesium with improvement.  His sodium levels improved with normal saline infusion and rehydration.  He had ongoing diarrhea, which was treated symptomatically with Imodium.  This was felt to be secondary to COVID-19 infection.  He had minimal respiratory symptoms, and remained stable on room air.  He did not meet criteria for treatment with IV remdesivir or oral Decadron. Pt on day of discharge reports feeling well. Diarrhea resolved and he has been tolerating PO foods >48 hrs. Discharged on 12/16 with sodium tabs x3 d. Will have follow up with PCP in 1 week.
COVID-19; COVID-19; This is a spontaneous report received from a contactable reporter (Consumer or other non HCP). The reporter is the patient.  A 75-year-old male patient received BNT162b2 (BNT162B2), on 21Jan2021 as dose 1, single (Lot number: EL1283), in left arm, on 11Feb2021 as dose 2, single (Lot number: EM9810), in left arm, on 23Sep2021 as dose 3 (booster) single (Lot number: 30135BA), in left arm and on 18Apr2022 as dose 4 (booster), single (Lot number: FK9093) at the age of 75 years, in left arm for COVID-19 immunization. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (unspecified date) Unknown results, notes: COVID 19 Treatment; (14Jun2022) Negative; (15Jun2022) Negative; (16Jun2022) Negative; (17Jun2022) Negative; (18Jun2022) Negative; (22Jun2022) positive. Therapeutic measures were taken as a result of drug ineffective, covid-19 which included Paxlovid.
Woke up in middle of night to use bathroom.  Experienced severe dizziness, felt like brain was sloshing around inside my skull.  Had trouble keeping balance.  Returned to bed, slept, experienced same dizziness in the morning when I woke up.  Felt better after having breakfast but very tired throughout day.  I took it easy and dizziness cleared up about mid day.  fortunately my husband was here to help.  I would have gone to clinic if symptoms had continued.  It is now 4/3/21 and I am not experiencing anything but slightly sore arm where vaccination was.
Patient developed reaction to injection site pm of injection. Area 10cm x 15cm, erythematous , firm, warm to touch, tender.
None, no adverse events. HD would like this form filled out because DTap was  given at age 8. Says it is ok and it is a viable booster.
High Heart rate; Fatigue; bad headache; achy; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 73 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 23Feb2021 (Lot number: EN6200) at the age of 73 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Cholesterol" (ongoing); "Bones" (ongoing); "Sleep" (ongoing); "Headaches" (ongoing). Concomitant medication(s) included: ATORVASTATIN taken for blood cholesterol (ongoing); CALCIUM taken for bone disorder (ongoing); ZOLPIDEM taken for sleep disorder; VITAMIN D taken for bone disorder (ongoing); ALEVE taken for headache. Vaccination history included: Bnt162b2 (Dose: 01, Caller states that she had all 3 doses on her Left arm., states that it might be R19265 or E19265 but she more so thinks it's E19265), administration date: 04Feb2021, when the patient was 73 years old, for Covid-19 immunization. The following information was reported: HEART RATE INCREASED (non-serious) with onset 23Feb2021, outcome "recovered" (Nov2021), described as "High Heart rate"; FATIGUE (non-serious) with onset 23Feb2021, outcome "recovered" (Nov2021), described as "Fatigue"; HEADACHE (non-serious) with onset 23Feb2021, outcome "recovered" (Nov2021), described as "bad headache"; PAIN (non-serious) with onset 23Feb2021, outcome "recovered" (Nov2021), described as "achy". Relevant laboratory tests and procedures are available in the appropriate section.  Additional information: After the vaccine she had a high heart rate, she was achy and fatigued. This was after the booster and after the second dose. It started the very same day as getting the second dose, but later in the day. The high heart rate, achy and fatigue subsided a couple days later. Allergies were none. Vaccination facility type was pharmacy or drug store. Prior vaccinations were none.  Follow-up attempts are completed. No further information is expected.
Decrease in amount of menstruation.; This is a spontaneous report received from a non-contactable reporter (Consumer or other non HCP). The reporter is the patient.  A 26-year-old female patient (not pregnant) received BNT162B2 (BNT162B2), administered in arm left, administration date 14Apr2021 (Lot number: ew0164) at the age of 26 years as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: HYPOMENORRHOEA (non-serious), outcome "unknown", described as "Decrease in amount of menstruation.". Additional Information: The patient and three of her other female friends experienced decrease in amount of menstruation. The patient did not receive other vaccine in four weeks. The patient has not been diagnosed with COVID prior vaccination and has not been tested for COVID post vaccination.   No follow-up attempts are possible. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021452460 same reporter, drug, event/different patients;US-PFIZER INC-2021452459 same reporter, drug, event/different patients;US-PFIZER INC-2021452461 same reporter, drug, event/different patients
Information has been received from a lawyer regarding a case in litigation concerning a female patient of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. On or about 02-JUN-2016, the patient was inoculated with the ZOSTAVAX (lot number, dosage and route of administration not provided), as recommended for routine adult health maintenance and for the prevention of shingles. ZOSTAVAX did not prevent shingles as intended, and the patient subsequently contracted a persistent strain of herpes zoster. Later in 2016, the patient was treated a blistering vesicular outbreak, which was diagnosed as herpes zoster, or shingles. As a direct and proximate result of the ZOSTAVAX, and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. The outcome of the events is unknown. Additional information has been requested.
Information has been received from a physician concerning a 15 year old patient who was vaccinated with a second dose of VARIVAX (Merck) (dose, route and lot number not reported). Physician reported that the patient received the second dose and still experienced chickenpox (20 or less vesicles). This physician was not the one that administered the vaccine, he only diagnosed the chickenpox in the patient. Patient sought for unspecified medical attention. This is one of several reports received from the same source. All telephone attempts to obtain follow-up information have been unsuccessful. Additional information is not expected.
My wife and I are both experiencing excruciating pain on the sides of our bodies where our flu shots were administered (and, in my case, this includes the specific area of the upper arm where I received the shot).  These symptoms commenced AFTER we each got sick with separate flu bugs a month or two after we received the shots - as if something latent in the vaccine was triggered by the illnesses we contracted.  I've had these symptoms for 12 days, commencing 2-3 days after I recovered from an intestinal illness.  My wife's symptoms also commenced 2-3 days after she got over a throat/respiratory illness.  Her symptoms were severe for 2 weeks, but have lingered to a lesser degree now for 7 weeks and counting.  I'm wondering if you've received any other complaints like this and if you have any recommendations for dealing with/curing these symptoms.  Thank you.
5/29/12 evening noticed shoulder itch and rash. Headache on exam 5/31/12 3:00 PM. Hive rash 10cm x 12cm on (R) deltoid.
After removing bandaid, noticed a papular eruption that looked like (to my visual inspection) like atopic vs contact dermatitis However, it centered around the vaccine sites.   given triamcinalone cream; reportedly resolved.
This case was reported by a pharmacist via call center representative and described the occurrence of tunnel vision in a 21-year-old female patient who received FLUARIX QUADRIVALENT (batch number C242G, expiry date June 2016). Concomitant products included OCELLA and ibuprofen. On 5th November 2015 08:00, the patient received FLUARIX QUADRIVALENT .5 ml. On 5th November 2015, several minutes after receiving FLUARIX QUADRIVALENT, the patient experienced tunnel vision (serious criteria GSK medically significant), nausea, felt faint, skin discoloration, numbness facial, headache and tingling lips. On 6th November 2015, the patient experienced fatigue and cold symptoms. On an unknown date, the outcome of the tunnel vision, nausea, felt faint, skin discoloration, numbness facial, headache, tingling lips, fatigue and cold symptoms were unknown. The reporter considered the tunnel vision, nausea, felt faint, skin discoloration, numbness facial, headache, tingling lips, fatigue and cold symptoms to be related to FLUARIX QUADRIVALENT. Additional details were provided as follows: The reporter called on the behalf of the patient (one of her pharmacy students). There were no other vaccines given on the same date or within 4 weeks prior to suspect vaccine. The time of vaccine administration of FLUARIX was 8:00pm. The reporter stated within a couple of minutes of receiving the injection the patient felt nauseated and almost fainted. In addition, the patient turned white as a ghost and experienced facial numbness, tunnel vision, headache and tingling around the lips. The reporter also stated that when she spoke with the patient at the time of reporting, she was still experiencing a headache, nausea and tingling around her lip and extreme fatigue (she could hardly move). Prior to receiving the injection the patient was fine and then after she became a different person. The patient stated although she just had exam week she felt ran down and thought she was developing cold symptoms. The patient's date of birth and complete expiration date of the vaccination were unknown.
Information has been received from a medical assistant referring to 5 unspecified patients of unknown age and gender. On unknown dates the patients were vaccinated with doses of improperly stored PROQUAD (Merck) (dose, strength and route were unknown, lot # reported as L034932, expiry date: 03-MAR-2017). No adverse effects were reported. This case is one of several cases received from the same source. Additional information has been requested.
some of the vaccine sprayed out while giving 1st dose using Vanish point needle; repeated full dose of 1st dose in the other arm(right arm); A spontaneous report was received from a Healthcare Professional (HCP) to report a 33 year old female patient who received Moderna's COVID-19 Vaccine, and who experienced some of the vaccine sprayed out while giving 1st dose using Vanish point needle (incorrect dose administered) and who received a repeated full dose of 1stdose in the other arm(right arm).  The patient's medical history was not provided. Concomitant product use was not provided by the reporter.  On an 15 Mar 2021 prior to the onset of events, the patient received their first dose of mRNA-1273 (lot number 001B21A) via intramuscular route in her left arm for COVID-19 infection prophylaxis. On same date 15 Mar 2021, the patient received a repeated full doses of mRNA-1273 (lot number 001B21A) via intramuscular in her right arm for COVID-19 infection prophylaxis.  Action taken with mRNA-1273 in response to the events was reported as unknown.  The outcome of the event was resolved at the time of this report.; Reporter's Comments: This report refers to a case of incorrect dose administered, and overdose for mRNA-1273, lot # 001B21A with no associated AEs.
swollen  axillary lymph nodes; tender axillary lymph nodes; sore neck on the side of the injection.; Lots of nausea; This is a spontaneous report received from a contactable other Health care professional. A 35-year-old non-pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6204), via an unspecified route of administration in her left arm on 16Mar2021 at 13:15 (at the age of 35-years-old), for covid-19 immunisation. The patients medical history included penicillin allergy. Past drug history included first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EL9266), via an unspecified route of administration in her left arm on 23Feb2021 at 13:45 for covid-19 immunisation. Concomitant medications were not reported. The patient has not received any other vaccines within 4 weeks prior to the COVID-19 vaccine. The patient has not tested positive for COVID-19 since having the vaccine. The patient has not diagnosed with COVID-19 prior to vaccination. On 16Mar2021, the patient experienced lots of nausea and on 18Mar2021 the patient experienced swollen and tender axillary lymph nodes and also had sore neck on the side of the injection. The clinical outcome for the events experienced nausea, swollen and tender axillary lymph nodes and sore neck was not recovered. The patient did not receive any treatment for the reported events. No follow-up attempts are needed. No further information is expected.
Sore arm and sore breasts. Had to have a biopsy done on my breast because there was a lump on my mammogram. Then, I got pregnant, and had a miscarriage at 18 weeks pregnant.
Extreme fatigue for 2 days. Swelling, redness and heat in local area to administration from 11/17 and continuing through today 11/22.
Body flush like when getting CT scan dye,  leg weakness,, nausea,, swollen tongue, feeling like throat closed over difficulty breathing. Happened immediately after getting J & J covid vaccine.
Flu-like symptoms, fever, chills, vomiting, diarrhea, aches, fatigue, dry-mouth, weakness.
Heart rate 110; This is a spontaneous report from a contactable nurse. A 39-year-old female patient received bnt162b2 (BNT162B2 lot number and expiration date were not reported) intramuscular at the right arm first dose on 19Dec2020 09:00 at a single dose for immunization. The patient had no relevant medical history. The patient's concomitant medications were not reported. On 19Dec2020 11:00, the patient experienced heart rate 110. No treatment was received for the adverse event. The most recent COVID-19 vaccine was administered in a hospital. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. No other medication was received within 2 weeks of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, has the patient has not been tested for COVID-19. No Allergies to medications, food, or other products. Outcome of the event was unknown.
Received Pfizer COVID-19 vaccines on 12/21/2020 and 1/13/2021.    On 4/17/2021 developed cough and congestion.  Tested positive for COVID.
Patient states that the day after yellow fever administration the site became "red, swollen, and itchy". Denies other symptoms. Denies any treatment. On 3/1/2012, the assessed area was red approximately 1 inch in diameter. Pt reports occassional itching. Denies other symptoms.
Pt reports severe discomfort right shoulder beginning with in 24 hours and continuing for 2 weeks. Unable to lift arm. Receives 6 doses Ibuprofen per day to move arm and to sleep.
Felt enlarged supraclavicular lymph node (2cm) right side.  No treatment necessary.
Hallucinations & Headache Narrative: Employee states that she woke up hallucinating, thinking someone had come and stolen items off of her back porch. Denies history of previous psychiatric conditions. She was so alarmed that she actually called the police. States shortly after speaking with officer, she realize that her items were all there and she hadn't been robbed. States is feeling fine today but concerned about whether she should receive a second vaccine.
nose bleed; flu; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of EPISTAXIS (nose bleed) and INFLUENZA (flu) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EPISTAXIS (nose bleed) and INFLUENZA (flu). At the time of the report, EPISTAXIS (nose bleed) and INFLUENZA (flu) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       no concomitant medication was reported  no treatment medication was reported
next 2 days I felt like I had a real severe case of the flu,  I had a hard time breathing, fever, hot flashes, chills. Now I have a bad cold and high blood pressure.  I was very pale.  Friday, Saturday felt the same, finally Sunday I felt good enough to get out and I returned to work today Monday. Took Advil and soaked in jacuzzi.